Tech Company Financing Transactions

Aradigm Funding Round

Aradigm, based in Bethesda, scored $20 million from Frist Cressey Venture, Andreessen Horowitz and JPMorgan Chase Bank.

Transaction Overview

Company Name
Announced On
12/10/2025
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Proceeds Purpose
Series A funding round that it intends to use to further enhance platform development, building out its team and growing its partnerships with payers and providers.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
7432 Hampden Lane
Bethesda, MD 20814
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Aradigm is on a mission to create sustainable, affordable access to life-saving medicines through a novel financial and delivery model that brings together every stakeholder -- payers, providers, manufacturers, and, most importantly, patients.
Profile
Aradigm LinkedIn Company Profile
Social Media
Aradigm Company Twitter Account
Company News
Aradigm News
Facebook
Aradigm on Facebook
YouTube
Aradigm on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Will Shrank
  Will Shrank LinkedIn Profile  Will Shrank Twitter Account  Will Shrank News  Will Shrank on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/10/2025: Mondu venture capital transaction
Next: 12/10/2025: GoDutch venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to report on tech company VC transactions. VC transactions on this site are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary